GR3020719T3 - N-Phenyl-N-(4-piperidinyl)amides useful as analgesics - Google Patents

N-Phenyl-N-(4-piperidinyl)amides useful as analgesics

Info

Publication number
GR3020719T3
GR3020719T3 GR960402083T GR960402083T GR3020719T3 GR 3020719 T3 GR3020719 T3 GR 3020719T3 GR 960402083 T GR960402083 T GR 960402083T GR 960402083 T GR960402083 T GR 960402083T GR 3020719 T3 GR3020719 T3 GR 3020719T3
Authority
GR
Greece
Prior art keywords
lower alkyl
group
alkoxy
member selected
carbonyl
Prior art date
Application number
GR960402083T
Other languages
English (en)
Inventor
Paul L Feldman
Michael K James
Marcus F Brackeen
Michael Ross Johnson
Harry Jefferson Leighton
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of GR3020719T3 publication Critical patent/GR3020719T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR960402083T 1989-02-15 1996-08-02 N-Phenyl-N-(4-piperidinyl)amides useful as analgesics GR3020719T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31131189A 1989-02-15 1989-02-15
US07/448,497 US5019583A (en) 1989-02-15 1989-12-11 N-phenyl-N-(4-piperidinyl)amides useful as analgesics

Publications (1)

Publication Number Publication Date
GR3020719T3 true GR3020719T3 (en) 1996-11-30

Family

ID=26977841

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402083T GR3020719T3 (en) 1989-02-15 1996-08-02 N-Phenyl-N-(4-piperidinyl)amides useful as analgesics

Country Status (22)

Country Link
US (1) US5019583A (el)
EP (1) EP0383579B1 (el)
JP (1) JP2895145B2 (el)
KR (1) KR0160979B1 (el)
AT (1) ATE140451T1 (el)
AU (1) AU636330B2 (el)
CA (1) CA2010011C (el)
CY (1) CY2002A (el)
CZ (1) CZ402591A3 (el)
DE (2) DE19675028I2 (el)
DK (1) DK0383579T3 (el)
ES (1) ES2088961T4 (el)
GR (1) GR3020719T3 (el)
HK (1) HK78297A (el)
IE (1) IE77156B1 (el)
LU (1) LU90011I2 (el)
MX (1) MX9203024A (el)
NL (1) NL960030I2 (el)
NZ (1) NZ232542A (el)
PT (1) PT93137B (el)
SG (1) SG47967A1 (el)
SK (1) SK402591A3 (el)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5466700A (en) * 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) * 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
JP4754068B2 (ja) * 1997-12-24 2011-08-24 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類
US6858018B1 (en) * 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
BR0016063A (pt) 1999-12-06 2002-08-06 Mallinckrodt Inc Métodos para a sìntese de alfentanila, sufentanila e remifentanila
WO2001068604A2 (en) 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
CA2417727C (en) * 2000-07-31 2009-09-01 Nycomed Danmark A/S Fentanyl composition for nasal administration
WO2002096351A2 (en) * 2001-04-03 2002-12-05 Aryx Therapeutics Ultrashort-acting opioids for transdermal application
JP2005516926A (ja) * 2001-12-17 2005-06-09 アリックス セラピューティクス 鎮痛薬の送達システム及び使用方法
WO2005030722A1 (ja) * 2003-09-29 2005-04-07 Nippon Chemiphar Co., Ltd. Ｎ－置換－ｎ－（４－ピペリジニル）アミド誘導体
CA2570075A1 (en) 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JPWO2006030931A1 (ja) * 2004-09-14 2008-05-15 日本ケミファ株式会社 Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
US20080319196A1 (en) * 2005-11-17 2008-12-25 Cheng Brian K Process for Synthesizing Remifentanil
JP2009524659A (ja) * 2006-01-24 2009-07-02 マリンクロッド・インコーポレイテッド レミフェンタニルの合成方法
US20080319197A1 (en) * 2006-02-03 2008-12-25 Cheng Brian K Crystalline Form of Remifentanil Hydrochloride
EP1867635A1 (en) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
PT2081921E (pt) 2006-07-10 2010-12-10 Paion Uk Ltd Sais de benzodiazepina de acção curta e suas formas polimórficas
WO2008045192A2 (en) * 2006-10-05 2008-04-17 Mallinckrodt Inc. Alternate process for remifentanil preparation
AU2007325889A1 (en) * 2006-11-29 2008-06-05 Mallinckrodt Inc. New process for remifentanil synthesis
WO2009146024A1 (en) * 2008-03-31 2009-12-03 The General Hospital Corporation Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
JP2011526257A (ja) * 2008-07-03 2011-10-06 シラグ アーゲー Ｎ−フェニル−ｎ−（４−ピペリジニル）アミド塩の製造方法
WO2010053944A1 (en) * 2008-11-04 2010-05-14 Cambrex Charles City, Inc. Improved method of making piperidine derivatives
CN102548964B (zh) 2009-07-10 2014-09-24 通用医疗公司 不抑制肾上腺皮质类固醇合成的依托咪酯类似物
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
EP3184512B1 (en) 2012-01-13 2020-12-23 The General Hospital Corporation Anesthetic compounds and related methods of use
CA2922340A1 (en) 2012-10-08 2014-04-17 Auckland Uniservices Limited Ketamine derivatives
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103728403B (zh) * 2013-08-30 2015-10-07 宜昌人福药业有限责任公司 一种盐酸瑞芬太尼原料药中有关物质的检测方法
ES2699636T3 (es) 2016-01-29 2019-02-12 Bioka S R O Nuevo procedimiento para la preparación de derivados de N-fenil-N-(4-piperidinil) amida, como remifentanilo y carfentanilo
EP3643704B1 (en) 2018-10-26 2020-12-16 hameln pharma gmbh New intermediates for the preparation of remifentanil hydrochloride
GB202010168D0 (en) 2020-07-02 2020-08-19 Johnson Matthey Plc Process for preparing remifentanil hydrochloride
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284196A (el) * 1961-10-10
US3655675A (en) * 1968-09-09 1972-04-11 Sterling Drug Inc N-(n-heteryl)-acylanilides
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4801721A (en) * 1984-08-16 1989-01-31 Ryan James W Stereospecific synthesis of carboxyalkyl peptides
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides

Also Published As

Publication number Publication date
HK78297A (en) 1997-06-20
KR0160979B1 (ko) 1998-12-01
IE900532L (en) 1990-08-15
US5019583A (en) 1991-05-28
DE69027794D1 (de) 1996-08-22
CA2010011C (en) 1997-12-02
EP0383579B1 (en) 1996-07-17
CA2010011A1 (en) 1990-08-15
ATE140451T1 (de) 1996-08-15
DK0383579T3 (da) 1996-10-14
MX9203024A (es) 1992-07-01
LU90011I2 (fr) 1997-03-11
KR900012906A (ko) 1990-09-03
DE19675028I2 (de) 2002-11-07
AU4973190A (en) 1990-08-23
JPH02300167A (ja) 1990-12-12
ES2088961T4 (es) 1996-12-01
SG47967A1 (en) 1998-04-17
PT93137B (pt) 1996-02-29
NL960030I1 (nl) 1997-02-03
EP0383579A1 (en) 1990-08-22
NL960030I2 (nl) 1997-05-01
ES2088961T3 (es) 1996-10-01
DE69027794T2 (de) 1997-01-02
AU636330B2 (en) 1993-04-29
SK402591A3 (en) 2000-09-12
IE77156B1 (en) 1997-12-03
NZ232542A (en) 1992-06-25
JP2895145B2 (ja) 1999-05-24
CY2002A (en) 1997-12-05
PT93137A (pt) 1990-08-31
CZ402591A3 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
EP0150787A3 (en) Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it
BR9912494A (pt) Derivado de di ou trifluorometanossulfonil anilida, processo para a sua produção e herbicida contendo o referido derivado como ingrediente ativo
NZ233970A (en) N-heteroaryl-purin-6-amines and pharmaceutical compositions
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
PT90725A (pt) Processo para a preparacao de novos compostos cefem
ATE246685T1 (de) Piperidone als tachykinin-hemmer
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
HU9302395D0 (en) Method for producing 4-/(benzothiazolyl)-methyl-amino/-alpha-/(3,4-difluorine-phenoxi)-methyl/-1-piperidine-ethanol
HUT50352A (en) Process for producing new antiviral prine derivatives and pharmaceutical compositions comprising same
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
DK0494604T3 (da) 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse
GR3005904T3 (el)
MY136018A (en) Di - or trifluoromethanesulfonyl anilide derivative, process for production thereof, and herbicide containing said derivative as active ingredient